Back to search

Peptide record

TPDB45809

Antiviral standard
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45809
Antiviral
Anti-infective peptides
DRAVP 2.0
standard
No
A 19-aa standard natural antiviral peptide sequence curated from DRAVP 2.0, with an available 3D structural model.
Sequence
GCRRLCGRLGRRLCRLLCR
Physicochemical Analysis
C90H170N40O20S4
ANDEQHIKMFPSTWYV
R
2260.84
12.00
7
0
5
+7
1.94
-0.195
102.63
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
250
11.06
4
Residue Composition
number
0
A
7
R
0
N
0
D
4
C
0
E
0
Q
3
G
0
H
0
I
5
L
0
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 7 N: 0 D: 0 C: 4 E: 0 Q: 0 G: 3 H: 0 I: 0 L: 5 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
19
C90H170N40O20S4
2260.84
12.00
+7
1.94
-0.195
Evidence Records 2 records
Evidence 1 Activity

Activity

MIC
Antiviral
60 µM

Target

Escherichia coli

Source & Reference

DRAVP 2.0

Other

hibited HSV-2MS in Vero cells (EC50 69.3 ug/ml) HSV-2MS in Vero cells (EC50 64.7 ug/ml). E. coli (MIC 60 uM) B.subtilis (MIC >120 uM).
Evidence 2 Activity

Activity

MIC
Antiviral
>120 µM

Target

B.subtilis

Source & Reference

DRAVP 2.0

Other

ro cells (EC50 69.3 ug/ml) HSV-2MS in Vero cells (EC50 64.7 ug/ml). E. coli (MIC 60 uM) B.subtilis (MIC >120 uM).